Global Lateral Flow Disease Testing Market by Applications, End Users, Growth Trends and Forecast to 2020

The global lateral flow disease testing market was valued at USD 5.1 Billion in 2015 and is estimated to reach USD 6.8 Billion by 2020, at a CAGR of 5.8% from 2016 to 2020, due increased drug resistant pathogens worldwide.

Browse Lateral Flow Disease Testing Market by Application (Hepatitis, HIV, Influenza, Malaria, Pregnancy, Syphilis), and End Users (Hospitals, Home Testing, Community Testing, Laboratory Testing) 2016-2020 at https://www.ihealthcareanalyst.com/report/lateral-flow-diagnostic-testing-market/

Lateral flow tests or immunochromatographic assays are conducted using simple devices in order to detect the presence (or absence) of a target analyte in a sample (matrix) without the need for specialized and costly equipment. Lateral flow test kits contains capillary beds such as sintered polymer or porous paper. Capillary beds consist of a sample pad that holds sample fluid and a conjugate pad. The conjugate pad is preloaded with conjugate that is dried form of bioactive substance that enables chemical reaction between target molecule (antigen) and its chemical partner (antibody) while the sample pad holds the sample fluid. Lateral flow tests are designed to deliver diagnostic results without proper laboratory setup. Typically, these tests are used for medical diagnostics either for home testing, point of care testing, or laboratory use. Lateral flow diagnostic tests or immunochromatography tests are diagnostic tests that deliver results in shortest timeframe.

The global lateral flow disease testing market report estimates the market size (Revenue USD million - 2013 to 2020) for market segmentation based on disease test (hepatitis, HIV, influenza, malaria, pregnancy, syphilis, etc.), and forecasts growth trends (CAGR% - 2016 to 2020). The global lateral flow disease testing market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global lateral flow disease testing market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating in the global lateral flow disease testing market and included in this report are Alere, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, EMD Millipore, F. Hoffmann-La Roche Ltd., Qiagen, and Siemens Healthcare.

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/lateral-flow-diagnostic-testing-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.